Veterinary Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Veterinary Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Market Overview:

The global veterinary vaccines market size reached US$ 12.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 21.5 Billion by 2028, exhibiting a growth rate (CAGR) of 9.3% during 2023-2028.

Veterinary vaccines represent bio-prepared immunizations that are administered to domestic animals or wild species through parenteral and oral routes to stimulate protective immune responses without causing the disease itself. They involve inactivated, live attenuated and recombinant vaccines as some common medications. These inoculations aid in reducing animal suffering, enhancing immune efficiency, and preventing the risk of developing and transmitting various contagious zoonotic diseases. Apart from this, veterinary vaccines are cost-effective, reliable, and offer long-term prevention, due to which they are also used to increase the production of livestock across the globe.

Veterinary Vaccines Market Trends:
The global veterinary vaccines market is majorly driven by the increasing demand for effective immunization products and the rising prevalence of various infectious epizootic disorders. This can be further attributed to the domestication of both companion and livestock animals across the globe and the enhanced focus on pet health. In line with this, extensive investments by governments in the pharmaceutical sector to improve novel veterinary vaccine manufacturing procedures are acting as another growth-inducing factor. Additionally, the introduction of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) vaccines with improved product stability, efficacy, and route administration approach is contributing to the market growth. Besides this, the innovation of intramuscular needle-free vaccine injections and growing awareness amongst consumers regarding their beneficial properties, such as enhanced safety and less pain, is propelling the market growth. Moreover, the fueling need for veterinary vaccines to prevent the transmission of disease-carrying microbes from livestock-based products, including milk, meat, leather, eggs, and wool, is positively stimulating the market growth. Other factors, such as significant improvements in the healthcare infrastructure, ongoing research and development (R&D) activities, and strategic collaborations amongst key players to enhance the efficiency of veterinary vaccines, are creating a positive outlook for the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global veterinary vaccines market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on vaccine type, technology, route of administration and distribution channel.

Breakup by Vaccine Type:

Livestock Vaccines
Bovine Vaccines
Poultry Vaccines
Porcine Vaccines
Others
Companion Animal Vaccines
Canine Vaccines
Feline Vaccines
Equine Vaccines

Breakup by Technology:

Attenuated Live Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Others

Breakup by Route of Administration:

Subcutaneous
Intramuscular
Intranasal

Breakup by Distribution Channel:

Veterinary Hospitals
Veterinary Clinics
Pharmacies and Drug Stores
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boehringer Ingelheim International GmbH, Ceva Santé Animale, Elanco Animal Health Incorporated, Hester Biosciences Limited, HIPRA, Indian Immunologicals Limited, Merck & Co. Inc., Neogen Corporation, Phibro Animal Health Corporation, Virbac SA and Zoetis Inc.

Key Questions Answered in This Report:
How has the global veterinary vaccines market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global veterinary vaccines market?
What are the key regional markets?
What is the breakup of the market based on the vaccine type?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the route of administration?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global veterinary vaccines market and who are the key players?
What is the degree of competition in the industry?